Novartis Adjusts Earnings Outlook Amid Strong Demand for Key Drugs
· gurufocus.com
On October 27, 2026, Swiss pharmaceutical giant Novartis (NVS) raised its full-year core operating profit forecast following robust demand for its key cancer an
On October 27, 2026, Swiss pharmaceutical giant Novartis NVS raised its full-year core operating profit forecast following robust demand for its key cancer and ...